Overestimating product reserves as loss of exclusivity (LoE) approaches can be a $75-million mistake
Jeffrey Borman, Integrichain, Inc.
Advertisement
Articles by Jeffrey Borman, Integrichain, Inc.
Advertisement
Latest Updated Articles
- Forecasting Returns When Patents Expire
Published: April 8th 2011 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
US News & World Report Reveals 2026 Best Medicare Advantage and Part D Companies
2
Cold Chain Technologies, Teva, and Kuehne+Nagel Proves Sea Freight Viable for High-Value Pharma Shipments
3
AstraZeneca Expands Texas Manufacturing Facility to Double Production of Hyperkalemia Drug
4
HDA 2025 Traceability Seminar: Pharma Supply Chain Nears Full DSCSA Compliance
5
